Log In | Register
The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment.
Stroke Prevention Study in Children with Sickle Cell Anemia, Iron Overload Stopped Early Experimental Approach Seems no Better Than Standard Treatment
Seeded on Fri Jun 4, 2010 5:47 PM EDT
Article Source: National Institutes of Health- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (0)
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.
